We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Seguimiento del paciente crónico durante la pandemia COVID-19 en la farmacia comunitaria: caso clínico.
- Authors
García Navarro, Caridad; Rodríguez-Arcas, María Jesús; Sánchez Ortiz, Juana María
- Abstract
The COVID-19 pandemic has been specially damaging for the monitoring of diabetic patients. During the pandemic, pharmacies, which have traditionally been the reference health-care centers for these patients, have been heavily involved in student-training, to respond to the increasingly demand of qualified healthcare professionals. During the training period, a 75-aged chronic patient with abdominal symptomatology and abnormally high values of glycosylated haemoglobin and triglycerides (7,7% and 309 mg/dl) was detected. The possible cause of the abdominal symptomatology was identified as a drug interaction between metformin and OCT1 transporters inhibitors. In addition, an adverse effect of prednisone was detected because of its hyperglycaemic effect, and a potential interaction between repaglinide and clopidogrel through CYP2C8 has been identified as a possible contributor to this condition. The negative drug results were notified to the physician in a written report. The doctor have accepted the pharmaceutical intervention and the drug treatment was modified. Three months later, the patient's values of glycosylated haemoglobin and triglycerides dropped to 6,8% and 122mg/dL respectively, both values within the optimum range, and the abdominal symptomatology highly decreased. To sum up, this case provides a clear example of how medication review with follow-up is an efficient tool to detect efficacy and security problems, and for improving the monitoring of chronic patients in collaboration with their physician.
- Publication
Farmacéuticos Comunitarios, 2022, Vol 14, Issue 2, p46
- ISSN
1885-8619
- Publication type
Article
- DOI
10.33620/FC.2173-9218.(2022/Vo!14).002